Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) submitted the application materials for the issuance of H shares and they have been received by the China Securities Regulatory Commission.

Anhui Huaheng Biotechnology Co., Ltd. (688639.SH) announced that on September 30, 2025, the company submitted an application to the Hong Kong Stock Exchange (HKEX) for the issuance of H shares and listing on the main board of HKEX. The application materials for this issuance and listing were published on the HKEX website on the same day. The company has also submitted the application materials for record filing with the China Securities Regulatory Commission (CSRC) in accordance with relevant regulations, and the CSRC has recently acknowledged receipt of the application.